However, the tumor tissue expression of GATA6 has been suggested to identify prognostic signatures in treatment-naive patients with pancreatic cancer (67), making it a prime candidate for further investigation in T cells. The gene discussed is GATA6; the disease is familial pancreatic carcinoma.